Budget’s funding welcome, but more is needed for pharmacy

PSA has welcomed the government’s commitment to pharmacy in the 2019-20 Federal Budget through the extension of the Administration Handling and Infrastructure (AHI) fee...

Listings for biosimilar uptake drivers expanded

Amended prescribing information has been released for two biosimilar uptake drivers listed on the Pharmaceutical Benefits Scheme (PBS), as part of the Biosimilar Awareness...

Pharmacists in 2023: Unlocking the opportunity

It’s time for PSA to reveal our vision of the future of pharmacy in Australia. I am pleased to announce our Pharmacists in 2023...

Local knowledge, local supplements

With consumer demand for health supplements increasing, a young established Australian supplier is aiming to better support of healthy lifestyle.

Out of the shadows  

Pharmacists are embracing new opportunities to play a greater role in multidisciplinary teams focused on mental health.  Australian Pharmacist spoke with two mental health...

How pharmacists can treat people with migraine

A look at the pharmacological and nonpharmacological treatment options and preventative measures that pharmacists can recommend to stave off migraine attacks. A common reason people...